Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Mounjaro for one month only is technically possible, but it is unlikely to produce the weight loss most people are hoping for. The medicine works by gradually shifting appetite and metabolism over weeks and months; a single four-week pen at the 2.5mg starting strength is a tolerability period, not a treatment course. That said, Mounjaro is a prescription-only medicine, and whether a short or extended course is right for you depends on a clinical assessment by a registered prescriber. This page sets out exactly what happens in month one, why duration matters, and how to think about the decision sensibly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every Mounjaro treatment course starts at 2.5mg. That is not a therapeutic dose in the same sense as 10mg or 15mg, its job is to introduce the medicine to your system gradually, reducing the chance of nausea, vomiting or other gastrointestinal symptoms that come with starting a GLP-1 or dual-agonist treatment. Think of it as your body learning to work alongside the medicine rather than fighting it.
During this first four weeks, most people notice their appetite shifting a little. Portions feel slightly smaller; certain foods feel less appealing. But the changes are modest at 2.5mg. The NHS medicines page for tirzepatide explains that treatment is titrated progressively, typically moving to 5mg after four weeks, then upward in similar steps under prescriber guidance. The weight-loss effect tends to accelerate as the dose increases, which is why month one alone rarely reflects what the medicine can do for you.
It is worth keeping the pen in a consistent spot in the fridge so the weekly routine becomes automatic; small habits like this make a longer course much easier to sustain.
If you take one pen and do not continue, a few things tend to happen. Appetite suppression fades relatively quickly once the medicine leaves your system. Weight that was beginning to shift often returns, because the biological signals that drive hunger come back to their previous levels. This is not a failure on your part, it reflects how the medicine works, and how weight biology responds when a treatment is withdrawn.
Research into GLP-1 medicines consistently shows that the majority of weight regain after stopping happens within months of discontinuation. The SURMOUNT-1 trial, whose results are published in the New England Journal of Medicine, was 72 weeks long precisely because meaningful and sustained weight reduction takes time to achieve and consolidate. Stopping at week four means leaving before the medicine has had a real chance to work.
None of this means a one-month course is wrong for every person. There are situations, such as a planned surgical procedure, a pregnancy, or a side-effect that cannot be managed, where stopping early is the clinically correct decision. If you are weighing up whether taking Mounjaro for one month only makes sense for your circumstances, it is worth understanding what that starting dose can and cannot tell you. You can read more about the considerations involved in whether Mounjaro is right for you on our overview page.
One practical point that surprises many patients: at nume) at nume, there are no automatic renewals. Every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is supplied. That means your decision about whether to continue is already built into the process. If after month one you have questions, side effects you want to discuss, or simply want to think it through, the right step is to raise that with the prescriber at your next review rather than quietly not reordering.
This is also where eligibility matters beyond the starting point. The BMI criteria for Mounjaro are one part of the picture, but prescribers also consider the BMI thresholds at which prescribing would be paused or stopped, as this shapes the clinical context around continuation decisions. If you have lost less than 5% of body weight after six months at the highest tolerated dose, NICE guidance on tirzepatide (TA1026) suggests that continuing should be reviewed. Month one is far too early for that kind of assessment, but it does illustrate how ongoing clinical judgement, not a fixed plan, shapes the course.
If cost is part of your thinking about whether to continue beyond a month, it is worth reading about how our treatment pricing works, where everything (clinical review, prescription, and next-working-day delivery) is included in a single transparent price.
The honest answer to "can I take Mounjaro for just one month?" is: yes, you can, and no prescriber will force you to continue. But it is worth going in with clear expectations. Month one is a starting point. The 2.5mg dose is not representative of what the treatment does at higher strengths. And the biological mechanisms that drive weight regain do not disappear after four weeks of appetite suppression.
For people who genuinely need a short trial (to see how the medicine sits with them before committing, or because circumstances limit the window) one month is a reasonable way to gather that information. Those wondering about using Mounjaro for one month as a way of testing their response will find a fuller discussion of what that experience typically involves on our dedicated page, and those considering a slightly longer window can find similar guidance on taking Mounjaro for two months only. For people who want meaningful, lasting weight loss, the evidence points clearly toward a longer course under ongoing clinical supervision.
Our clinical team, led by our Independent Prescriber, reviews every case individually. If you have questions about your specific situation before starting, the consultation is the right place to raise them, it is free, thorough, and assessed the same working day. There is more general context on what treatment involves at our weight management page if you want to read further before deciding.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.